Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is available in Belfast through a private prescription following a clinical assessment. It is a once-weekly injection licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related health condition. As a prescription-only medicine, a qualified prescriber must assess your suitability before any treatment can be dispensed — regardless of where in the UK you live. A GPhC-registered online pharmacy can prescribe and deliver to a Belfast address without you needing a local clinic appointment, provided that assessment happens properly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 study, published in the New England Journal of Medicine, randomised 2,539 adults with obesity but without type 2 diabetes. At 72 weeks, those on the 15 mg dose had lost an average of around 20–21% of their body weight. That is a meaningful figure, but the word "average" matters: some people lost considerably more, others less. Results depend on adherence to the treatment schedule, the diet and activity changes made alongside it, and individual physiology.
A later head-to-head study (SURMOUNT-5, also published in 2025) compared tirzepatide directly with semaglutide 2.4 mg and found tirzepatide produced greater average weight reduction. That comparison is now reflected in NICE's appraisal of tirzepatide (TA1026), which notes the indirect evidence favours tirzepatide. None of that makes it right for everyone; a prescriber still needs to weigh the full picture for your health specifically.
Mounjaro works by activating two gut-hormone receptors (GIP and GLP-1) that regulate appetite and blood sugar. The effect is a sustained reduction in hunger and slower gastric emptying. You learn to eat less not because you are forcing yourself, but because the drive to eat changes. For most people, the experience of that shift takes a few weeks to settle in, particularly as doses increase.
Northern Ireland has its own health service commissioning structure, so NHS access to tirzepatide does not follow exactly the same rollout timetable as England. As a general guide, NHS access in Northern Ireland remains limited and typically requires meeting strict criteria through specialist services. If you are hoping for an NHS prescription in Belfast, speak to your GP about what pathways are available locally, availability varies by trust and referral criteria are changing.
The private route is more straightforward in terms of access. A GPhC-registered online pharmacy can carry out a consultation remotely, review your details the same day, and dispatch treatment to a Belfast address by next working day if you are clinically suitable. You can confirm a pharmacy is legitimately registered by checking its entry on the GPhC pharmacy register, a search that takes under a minute and is worth doing for any provider you are considering. For context on how private pricing works across the UK, our breakdown of Mounjaro's UK cost changes covers what happened to list prices from September 2025 onwards.
At nume, consultations are reviewed by a named GPhC-registered Independent Prescriber, not software. If approved, treatment is dispatched the same day for orders placed before noon, arriving by tracked DPD delivery in plain packaging.
Treatment starts at the 2.5 mg dose. That first pen is not the therapeutic target; its job is to let your body adjust to the medicine before the dose moves upward, typically in four-week steps decided by your prescriber. The full dose range runs up to 15 mg, though many people find effective results at intermediate doses.
The most common side effects are gastrointestinal: nausea is the most frequently reported, followed by indigestion, changes in bowel habit and occasionally vomiting. These effects tend to peak in the first week or two after a dose increase and then ease. Staying well hydrated and eating smaller, lower-fat meals helps most people manage them. If you experience severe, persistent stomach pain that radiates toward your back, seek medical attention promptly, the MHRA has flagged acute pancreatitis as a known, if uncommon, risk with this class of medicine.
If you take an oral contraceptive pill, your prescriber will advise adding a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide can reduce absorption of oral medicines taken around the same time. Questions about how to eat and structure meals on treatment (including topics like what to eat at breakfast, whether using SlimFast alongside Mounjaro makes sense, or whether fasting fits safely into your routine while you are on Mounjaro) are ones our clinical team fields regularly. The short answer is always: discuss your specific plan with your prescriber first.
Mounjaro is a prescription-only medicine. Sellers offering it without a clinical assessment, via social media, or at prices dramatically below the market rate are operating outside the law. The MHRA has warned publicly about counterfeit weight-loss pens (including fake tirzepatide) and has made significant seizures of illegally traded product in the UK. Counterfeits have contained the wrong substances and caused real harm.
The practical check: look up any pharmacy on the GPhC register before you engage. If it is not listed, do not order. Discount codes for prescription medicines from unknown sellers are a red flag, not a saving. Report anything suspicious through the MHRA Yellow Card scheme.
If you have questions about whether Mounjaro is right for your situation, our FAQs cover a range of common scenarios, and our clinical team is available seven days a week for aftercare support. For a broader look at the medicine itself, the tirzepatide overview covers mechanism, dosing context and what to expect across the full treatment journey.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.